Richard B Parad

Summary

Affiliation: University of Massachusetts Medical School
Country: USA

Publications

  1. ncbi request reprint Diagnostic dilemmas resulting from the immunoreactive trypsinogen/DNA cystic fibrosis newborn screening algorithm
    Richard B Parad
    New England Newborn Screening Program, University of Massachusetts Medical School, Boston, Massachusetts 02130, USA
    J Pediatr 147:S78-82. 2005
  2. ncbi request reprint Sweat testing infants detected by cystic fibrosis newborn screening
    Richard B Parad
    New England Newborn Screening Program of University of Massachusetts Medical School, MA 02130, USA
    J Pediatr 147:S69-72. 2005
  3. doi request reprint Cystic fibrosis newborn screening: using experience to optimize the screening algorithm
    Jaime E Hale
    New England Newborn Screening Program, UMass Medical School, Jamaica Plain, MA 02130, USA
    J Inherit Metab Dis 33:S255-61. 2010
  4. ncbi request reprint Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: a cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections
    Anne Marie Comeau
    New England Newborn Screening Program of University of Massachusetts Medical School, Boston, Massachusetts 02130, USA
    Pediatrics 113:1573-81. 2004
  5. doi request reprint Prospective evaluation of a prenatal sonographic clubfoot classification system
    Michael P Glotzbecker
    Department of Orthopedics, Boston Children s Hospital, Boston, Mass, USA
    Fetal Diagn Ther 34:236-40. 2013
  6. ncbi request reprint Guidelines for implementation of cystic fibrosis newborn screening programs: Cystic Fibrosis Foundation workshop report
    Anne Marie Comeau
    New England Newborn Screening Program and Department of Pediatrics, University of Massachusetts Medical School, Worcester, Massachusetts, USA
    Pediatrics 119:e495-518. 2007
  7. doi request reprint Low urine vascular endothelial growth factor levels are associated with mechanical ventilation, bronchopulmonary dysplasia and retinopathy of prematurity
    Bernadette M Levesque
    Division of Newborn Medicine, Boston Children s Hospital, Boston, Mass, USA
    Neonatology 104:56-64. 2013
  8. ncbi request reprint Newborn screening for cystic fibrosis
    Richard B Parad
    Massachusetts Cystic Fibrosis Newborn Screening Program, University of Massachusetts Medical School, Department of Pediatrics, Harvard Medical School, Brigham and Women s Hospital, Children s Hospital, Boston, USA
    Pediatr Ann 32:528-35. 2003
  9. doi request reprint Reduction of retinopathy of prematurity in extremely low gestational age newborns treated with recombinant human Cu/Zn superoxide dismutase
    Richard B Parad
    Department of Newborn Medicine, Brigham and Women s Hospital, Boston, MA 02115, USA
    Neonatology 102:139-44. 2012
  10. doi request reprint Prenatally diagnosed clubfeet: comparing ultrasonographic severity with objective clinical outcomes
    Michael P Glotzbecker
    Children s Hospital Boston, Boston, MA 02115, USA
    J Pediatr Orthop 30:606-11. 2010

Detail Information

Publications14

  1. ncbi request reprint Diagnostic dilemmas resulting from the immunoreactive trypsinogen/DNA cystic fibrosis newborn screening algorithm
    Richard B Parad
    New England Newborn Screening Program, University of Massachusetts Medical School, Boston, Massachusetts 02130, USA
    J Pediatr 147:S78-82. 2005
    ....
  2. ncbi request reprint Sweat testing infants detected by cystic fibrosis newborn screening
    Richard B Parad
    New England Newborn Screening Program of University of Massachusetts Medical School, MA 02130, USA
    J Pediatr 147:S69-72. 2005
    ..Describe and define limitations of early pilocarpine iontophoresis (sweat testing) for cystic fibrosis (CF) newborn screening (NBS)...
  3. doi request reprint Cystic fibrosis newborn screening: using experience to optimize the screening algorithm
    Jaime E Hale
    New England Newborn Screening Program, UMass Medical School, Jamaica Plain, MA 02130, USA
    J Inherit Metab Dis 33:S255-61. 2010
    ....
  4. ncbi request reprint Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: a cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections
    Anne Marie Comeau
    New England Newborn Screening Program of University of Massachusetts Medical School, Boston, Massachusetts 02130, USA
    Pediatrics 113:1573-81. 2004
    ..The objective of this study was to evaluate technical feasibility and practical implications of 2-tiered CF newborn screening that uses testing for multiple mutations (multiple-CFTR-mutation testing)...
  5. doi request reprint Prospective evaluation of a prenatal sonographic clubfoot classification system
    Michael P Glotzbecker
    Department of Orthopedics, Boston Children s Hospital, Boston, Mass, USA
    Fetal Diagn Ther 34:236-40. 2013
    ..The purpose of this study was to prospectively evaluate our recently described fetal sonographic classification system for prenatal diagnosis of clubfoot...
  6. ncbi request reprint Guidelines for implementation of cystic fibrosis newborn screening programs: Cystic Fibrosis Foundation workshop report
    Anne Marie Comeau
    New England Newborn Screening Program and Department of Pediatrics, University of Massachusetts Medical School, Worcester, Massachusetts, USA
    Pediatrics 119:e495-518. 2007
    ....
  7. doi request reprint Low urine vascular endothelial growth factor levels are associated with mechanical ventilation, bronchopulmonary dysplasia and retinopathy of prematurity
    Bernadette M Levesque
    Division of Newborn Medicine, Boston Children s Hospital, Boston, Mass, USA
    Neonatology 104:56-64. 2013
    ..Urine VEGF is easily measured and useful in early diagnosis of several diseases...
  8. ncbi request reprint Newborn screening for cystic fibrosis
    Richard B Parad
    Massachusetts Cystic Fibrosis Newborn Screening Program, University of Massachusetts Medical School, Department of Pediatrics, Harvard Medical School, Brigham and Women s Hospital, Children s Hospital, Boston, USA
    Pediatr Ann 32:528-35. 2003
    ..For developing therapies, Massachusetts will have identified its CF patients before they have sustained significant malnutrition and lung injury, and it may be these patients who will benefit most from therapies still on the horizon...
  9. doi request reprint Reduction of retinopathy of prematurity in extremely low gestational age newborns treated with recombinant human Cu/Zn superoxide dismutase
    Richard B Parad
    Department of Newborn Medicine, Brigham and Women s Hospital, Boston, MA 02115, USA
    Neonatology 102:139-44. 2012
    ..Reactive oxygen species have been implicated in the pathogenesis of retinopathy of prematurity (ROP). Extremely low gestational age (GA) newborns (ELGANs) have the highest risk of ROP and might benefit most from treatment with antioxidants...
  10. doi request reprint Prenatally diagnosed clubfeet: comparing ultrasonographic severity with objective clinical outcomes
    Michael P Glotzbecker
    Children s Hospital Boston, Boston, MA 02115, USA
    J Pediatr Orthop 30:606-11. 2010
    ..The purpose of this study was to decrease the false positive (FP) rate for prenatally identified clubfeet, and to predict clinical severity using a new prenatal sonographic classification system...
  11. pmc Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report
    Philip M Farrell
    Department of Pediatrics and Population Health Sciences, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA
    J Pediatr 153:S4-S14. 2008
    ..Their recommendations, presented herein, involve a combination of clinical presentation, laboratory testing, and genetics to confirm a diagnosis of CF...
  12. doi request reprint Newborn screening showing decreasing incidence of cystic fibrosis
    Jaime E Hale
    N Engl J Med 358:973-4. 2008
  13. ncbi request reprint Balancing benefits and risks for cystic fibrosis newborn screening: implications for policy decisions
    Benjamin S Wilfond
    Social and Behavioral Research Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland 20892, USA
    J Pediatr 147:S109-13. 2005
    ....
  14. ncbi request reprint Pulmonary outcome at 1 year corrected age in premature infants treated at birth with recombinant human CuZn superoxide dismutase
    Jonathan M Davis
    Department of Pediatrics Neonatology, CardioPulmonary Research Institute, Winthrop University Hospital, SUNY Stony Brook School of Medicine, Mineola, New York 11501, USA
    Pediatrics 111:469-76. 2003
    ..To examine whether treatment of premature infants with intratracheal recombinant human CuZn superoxide dismutase (r-h CuZnSOD) reduces bronchopulmonary dysplasia and improves pulmonary outcome at 1 year corrected age...